Hospital
Prime Healthcare Anaheim, LLC
Prime Healthcare Anaheim, LLC was paid $8.85M by Medicaid between Jan 2018 and Dec 2024, across 177 billing codes. Its largest line is 0450, Emergency room services — 9.4% of everything it billed.
33Billing provider infoPRIME HEALTHCARE ANAHEIM, LLC
ANAHEIM, CA 92804
ANAHEIM, CA 92804
33aNPI1871501916assigned 08/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.85M
24GClaims761,922
24DCodes billed177
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#193 of 410
Median peer was paid$6.90M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 110,896 | $995K | |
| 2019 | 109,686 | $1.25M | |
| 2020 | 103,731 | $1.23M | |
| 2021 | 119,066 | $1.16M | |
| 2022 | 138,486 | $1.45M | |
| 2023 | 112,674 | $1.64M | |
| 2024incomplete | 67,383 | $1.12M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 9.4% | 73,247 | 60,671 | $833K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7.1% | 17,420 | 13,703 | $628K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.5% | 7,820 | 6,545 | $571K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.0% | 11,476 | 9,393 | $441K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.7% | 9,241 | 8,093 | $417K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.5% | 8,779 | 6,854 | $396K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 4.5% | 10,566 | 7,622 | $394K |
| Z7502 | 4.0% | 9,396 | 9,177 | $355K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.2% | 12,529 | 9,466 | $284K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 1,877 | 1,563 | $278K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.0% | 22,044 | 17,583 | $264K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.7% | 13,795 | 10,641 | $236K |
165 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.5% | 5,413 | $220K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 45,491 | $193K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 12,003 | $175K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2.0% | 2,504 | $174K |
| 80053 | Comprehensive metabolic panel | 1.9% | 30,236 | $166K |
| J3490 | Unclassified drugs | 1.7% | 30,636 | $152K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.6% | 4,313 | $145K |
| 71045 | Radiologic examination, chest; single view | 1.4% | 17,113 | $123K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.3% | 20,039 | $115K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 1.2% | 738 | $106K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 4,500 | $98K |
| 99199 | Unlisted special service, procedure or report | 1.0% | 1,761 | $93K |
| 84484 | <1% | 14,191 | $69K | |
| 83690 | <1% | 18,078 | $66K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,309 | $64K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 14,978 | $63K |
| 72131 | <1% | 959 | $62K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,588 | $62K |
| 99283 | Emergency room visit (moderate) | <1% | 5,262 | $62K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,076 | $60K |
| 0270 | <1% | 58,839 | $60K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 14,713 | $59K |
| Z7610 | <1% | 5,123 | $58K | |
| 90715 | <1% | 2,493 | $55K | |
| 93971 | <1% | 714 | $55K | |
| 83880 | <1% | 3,564 | $55K | |
| 99285 | Emergency room visit (most serious) | <1% | 2,091 | $52K |
| 81001 | <1% | 32,863 | $51K | |
| 81025 | <1% | 18,767 | $50K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,329 | $50K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,816 | $44K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 13,449 | $43K |
| 99284 | Emergency room visit (serious) | <1% | 2,048 | $41K |
| 70486 | <1% | 599 | $37K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 9,650 | $37K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,002 | $36K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,508 | $34K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,385 | $33K |
| 72193 | <1% | 268 | $32K | |
| 71250 | <1% | 584 | $31K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,474 | $27K |
| 87040 | <1% | 6,279 | $26K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,209 | $23K |
| 87428 | <1% | 464 | $21K | |
| 73562 | <1% | 1,614 | $21K | |
| 73610 | <1% | 1,394 | $19K | |
| 73630 | <1% | 1,392 | $19K | |
| 83605 | <1% | 4,028 | $18K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,243 | $18K |
| 76801 | <1% | 422 | $18K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,247 | $18K |
| 73030 | <1% | 1,337 | $17K | |
| 73130 | <1% | 1,128 | $16K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,651 | $15K |
| 87186 | <1% | 3,440 | $15K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 942 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,322 | $14K |
| 85379 | <1% | 2,584 | $13K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,247 | $13K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 3,062 | $13K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 3,227 | $12K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,354 | $11K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,452 | $11K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,689 | $11K |
| 85610 | <1% | 5,222 | $9K | |
| 76830 | Ultrasound, transvaginal | <1% | 243 | $9K |
| 87088 | <1% | 2,060 | $8K | |
| 82962 | <1% | 5,007 | $7K | |
| 73110 | <1% | 489 | $6K | |
| 0250 | <1% | 7,100 | $6K | |
| 70496 | <1% | 33 | $6K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,840 | $6K |
| 84702 | <1% | 1,029 | $6K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,210 | $5K |
| 87077 | <1% | 1,229 | $5K | |
| 85730 | <1% | 1,820 | $5K | |
| 87070 | <1% | 2,135 | $5K | |
| 10060 | <1% | 355 | $4K | |
| 96376 | <1% | 2,128 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 424 | $4K |
| 73080 | <1% | 264 | $4K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 422 | $3K |
| 70498 | <1% | 33 | $3K | |
| 0011A | <1% | 77 | $3K | |
| 0012A | <1% | 76 | $3K | |
| 12001 | <1% | 342 | $3K | |
| 87420 | <1% | 1,696 | $3K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 90 | $3K |
| 0272 | <1% | 4,459 | $3K | |
| 83735 | <1% | 879 | $3K | |
| 29125 | <1% | 787 | $2K | |
| 0160 | <1% | 266 | $2K | |
| 82805 | <1% | 201 | $2K | |
| 84145 | <1% | 188 | $2K | |
| 96367 | <1% | 105 | $2K | |
| 80076 | <1% | 373 | $2K | |
| 86901 | <1% | 1,120 | $2K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,805 | $2K |
| 86900 | <1% | 1,116 | $2K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 249 | $2K |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 252 | $2K |
| 74018 | <1% | 192 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 30 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 46 | $1K |
| 93970 | <1% | 16 | $1K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $1K |
| J1815 | Injection, insulin, per 5 units | <1% | 261 | $1K |
| 29515 | <1% | 310 | $1K | |
| 99070 | <1% | 269 | $1K | |
| 73090 | <1% | 96 | $957.41 | |
| 12011 | <1% | 97 | $894.35 | |
| 85651 | <1% | 665 | $833.79 | |
| 82947 | <1% | 286 | $814.68 | |
| 73590 | <1% | 65 | $742.76 | |
| 85027 | <1% | 2,015 | $702.40 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 700 | $650.36 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 166 | $528.61 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 14 | $460.77 |
| 94762 | <1% | 61 | $429.02 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 103 | $428.72 |
| 87205 | <1% | 184 | $334.26 | |
| 72100 | <1% | 13 | $313.44 | |
| 73620 | <1% | 26 | $303.96 | |
| 29505 | <1% | 74 | $283.32 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 51 | $269.69 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $266.73 |
| 73140 | <1% | 29 | $214.64 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 21 | $206.27 |
| 86850 | <1% | 144 | $201.15 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 65 | $198.73 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 513 | $192.24 |
| 0301 | <1% | 1,060 | $191.85 | |
| 71101 | <1% | 15 | $175.84 | |
| 87210 | <1% | 64 | $155.30 | |
| 87299 | <1% | 20 | $149.15 | |
| 87184 | <1% | 64 | $132.32 | |
| 0271 | <1% | 65 | $111.53 | |
| 82550 | <1% | 37 | $95.67 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 16 | $91.24 |
| J2704 | Injection, propofol, 10 mg | <1% | 24 | $77.77 |
| 12002 | <1% | 12 | $75.84 | |
| 0636 | <1% | 716 | $75.17 | |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 19 | $62.97 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 16 | $53.65 |
| 81005 | <1% | 144 | $52.95 | |
| 81003 | <1% | 593 | $51.71 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 15 | $36.00 |
| 82803 | <1% | 17 | $23.93 | |
| 85008 | <1% | 292 | $8.16 | |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 40 | $1.82 |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 540 | $0.00 |
| 0305 | 0% | 493 | $0.00 | |
| G0411 | Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | 0% | 2,968 | $0.00 |
| 0307 | 0% | 117 | $0.00 | |
| 0306 | 0% | 346 | $0.00 | |
| 0352 | 0% | 140 | $0.00 | |
| 0324 | 0% | 177 | $0.00 | |
| 0710 | 0% | 17 | $0.00 | |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 696 | $0.00 |
| G0176 | Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more) | 0% | 824 | $0.00 |
| 0402 | 0% | 74 | $0.00 | |
| 0320 | 0% | 120 | $0.00 | |
| 0351 | 0% | 71 | $0.00 | |
| G0479 | Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of service | 0% | 52 | $0.00 |
| 0300 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHELL, TROY (SECRETARY / GENERAL COUNSEL)
| Provider | Location | Paid |
|---|---|---|
| Prime Healthcare Services - ST. Mary's Passaic LLC | Passaic, NJ | $56.16M |
| Prime Healthcare Services - ST. Mary's Passaic, LLC | Passaic, NJ | $7.25M |
| Prime Healthcare Services Encino LLC | Encino, CA | $1.52M |
| Prime Healthcare Services - ST. Mary's Passaic, LLC | Passaic, NJ | $342K |
| Prime Healthcare Services - ST. Mary's Passaic, LLC | Passaic, NJ | $9K |
| Prime Healthcare Centinela LLC | Inglewood, CA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.